Skip to Content
Merck
CN

Key Documents

View All Documentation

MKI2MAG-94K

MILLIPLEX® Mouse Kidney Injury Panel

Configurable Mouse Kidney Injury 5-Plex Panel 2

Synonym(s):

kidney inflammation marker listing, mouse kidney biomarker panel, mouse kidney disease assay, mouse renal damage detection panel, mouse renal health research tool, multiplex kidney profiling kit, renal function biomarker panel, renal injury multiplex kit

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

Product Name

MILLIPLEX® Mouse Kidney Injury Panel,

description

Configurable Mouse Kidney Injury 5-Plex Panel 2

species reactivity

mouse

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 90-99%, sensitivity: 0.005-0.190 ng/mL
(MinDC+2SD), standard curve range: 0.005-5 ng/mL
(Lipocalin-2/NGAL), standard curve range: 0.01-10 ng/mL
(Osteopontin (OPN)), standard curve range: 0.04-40 ng/mL
(EGF), standard curve range: 0.05-50 ng/mL
(Cystatin C), standard curve range: 0.2-250 ng/mL
(Clusterin)

technique(s)

multiplexing: suitable

input

serum
plasma
urine

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Kidney injury can result from drug toxicity, metabolic disorders, or systemic disease. Traditional markers like BUN and creatinine are often insensitive and non-specific. This panel—Clusterin, Cystatin C, EGF, NGAL/Lipocalin-2, and Osteopontin (OPN)—captures key indicators of renal damage, inflammation, and tissue remodeling. The MILLIPLEX® Mouse Kidney Injury Panel 2 enables multiplexed quantification of these biomarkers in mouse urine, serum, or plasma, supporting research in nephrotoxicity, renal disease, and therapeutic development.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze kidney injury-related biomarkers in mouse urine, serum, or plasma samples.

Analytes Included: Clusterin, Cystatin C, EGF, NGAL/Lipocalin-2, Osteopontin (OPN) EGF has not been analytically validated in serum/plasma samples and can only be run with urine samples

Assay Characteristics: Refer to assay protocol for details on cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:

  • Targets biomarkers involved in renal injury, inflammation, and tissue remodeling
  • Includes 5 analytes relevant to nephrotoxicity and kidney function assessment
  • Multiplex format enables simultaneous detection from minimal sample volume
  • Compatible with mouse urine, serum, and plasma samples
  • Designed for research in acute kidney injury, drug-induced nephrotoxicity, and renal disease models
Benefits:

  • Provides a focused profile of kidney injury biomarkers in mouse models
  • Supports investigation of renal damage mechanisms and therapeutic evaluation
  • Facilitates early detection of nephrotoxicity and disease progression
  • Enables high-throughput analysis with reduced sample and reagent use
  • Delivers reproducible, sensitive results for preclinical and translational research

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Still not finding the right product?

Explore all of our products under MILLIPLEX® Mouse Kidney Injury Panel

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Regulatory Information

新产品

This item has

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Related Content

Overview of Luminex® Multiplex Assay Technology | MILLIPLEX® Multiplex Assays

Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.

Multiplex Toxicity Assays | MILLIPLEX® Assays

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

Nephrotoxicity Analysis with Kidney Toxicity Multiplex Assays | MILLIPLEX® Assays

Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.

View All Related Content

Global Trade Item Number

SKUGTIN
MKI2MAG-94K04055977114690